ROMANO, ELOISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.433
EU - Europa 2.396
AS - Asia 656
AF - Africa 11
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 6.501
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.426
RU - Federazione Russa 971
PL - Polonia 501
IT - Italia 292
IE - Irlanda 248
SE - Svezia 201
SG - Singapore 197
CN - Cina 167
HK - Hong Kong 128
IN - India 81
FI - Finlandia 46
JO - Giordania 45
DE - Germania 36
GB - Regno Unito 36
VN - Vietnam 18
BE - Belgio 13
CH - Svizzera 12
ES - Italia 11
UA - Ucraina 11
CI - Costa d'Avorio 10
KR - Corea 8
CA - Canada 7
TR - Turchia 6
JP - Giappone 4
LU - Lussemburgo 4
NL - Olanda 4
AU - Australia 3
FR - Francia 3
AT - Austria 2
RO - Romania 2
BR - Brasile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EU - Europa 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
TN - Tunisia 1
Totale 6.501
Salva come PNG Salva come JPEG
Città #
Santa Clara 781
Warsaw 500
Fairfield 433
Ashburn 246
Chandler 244
Dublin 244
Woodbridge 208
Seattle 177
Singapore 173
Houston 161
Cambridge 155
Wilmington 127
Florence 89
Ann Arbor 78
Hong Kong 76
Lawrence 71
Altamura 69
Beijing 63
Princeton 57
Mumbai 53
Boston 40
Moscow 36
Shanghai 32
San Diego 26
Boardman 20
Medford 19
Fiesole 17
Milan 17
Pune 17
New York 16
Dong Ket 14
Helsinki 14
Falls Church 13
Buffalo 12
Jacksonville 12
Kent 12
Hillsboro 11
Munich 11
Abidjan 10
West Jordan 10
Brussels 7
Castelliri 7
London 7
Sesto Fiorentino 7
Yubileyny 7
Andover 6
Bern 6
Izmir 6
Lappeenranta 6
Seoul 6
Toronto 6
Redwood City 5
Romola 5
Shenzhen 5
Barcelona 4
Kochi 4
Madrid 4
Norwalk 4
Rome 4
Scandicci 4
Tappahannock 4
Guangzhou 3
Kilburn 3
Louvain-la-Neuve 3
Nanjing 3
New Delhi 3
Perth 3
Phoenix 3
Washington 3
Arezzo 2
Camerino 2
Catania 2
Chengdu 2
Forest City 2
Gazzo 2
Genoa 2
Ghent 2
Hangzhou 2
Latina 2
Llagostera 2
Los Angeles 2
Manchester 2
Matsuyama 2
Monmouth 2
New Market 2
North Bergen 2
Padova 2
Prato 2
Rui'an 2
Saint-Fons 2
Salerno 2
Scarperia e San Piero 2
Sparks 2
St Petersburg 2
Sunderland 2
Thrissur 2
Tianjin 2
Wallisellen 2
Wuhan 2
Wuxi 2
Totale 4.564
Salva come PNG Salva come JPEG
Nome #
Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis 252
Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosis 236
Decreased expression of the endothelial cell-derived factor EGFL7 in systemic sclerosis: potential contribution to impaired angiogenesis and vasculogenesis 216
Clinical, instrumental, serological and histological findings suggest that hemophilia B may be less severe than hemophilia A 176
Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis 153
Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells 151
Agonistic anti-human Fas monoclonal antibody induces fibroblast-like synoviocyte apoptosis in haemophilic arthropathy: potential therapeutic implications 137
TNF-α/TNF-R System May Represent a Crucial Mediator of Proliferative Synovitis in Hemophilia A 134
Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis 131
Angiotensin II type 2 receptor (AT2R) as a novel modulator of inflammation in rheumatoid arthritis synovium 128
Decrease of LL-37 in systemic sclerosis: a new marker for interstitial lung disease? 127
The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis 126
Neuropeptides activate TRPV1 in rheumatoid arthritis fibroblast-like synoviocytes and foster IL-6 and IL-8 production. 126
Differential expression of junctional adhesion molecules in different stages of systemic sclerosis 125
Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro 123
Evidence for a Derangement of the Microvascular System in Patients with a Very Early Diagnosis of Systemic Sclerosis 118
Systemic Sclerosis Serum Steers the Differentiation of Adipose-Derived Stem Cells Toward Profibrotic Myofibroblasts: Pathophysiologic Implications 115
Enthesopathy and involvement of synovio-entheseal complex in systemic sclerosis: an ultrasound pilot study 113
Disease Activity Improvement in Rheumatoid Arthritis Treated with Tumor Necrosis Factor-α Inhibitors Correlates with Increased Soluble Fas Levels. 110
A two-step immunomagnetic microbead-based method for the isolation of human primary skin telocytes/CD34+ stromal cells 109
Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage 106
THE CROSSTALK OF THE SKIN-ORAL-GUT MICROBIOME AXIS IN LIMITED AND DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS 105
Glycolysis-derived acidic microenvironment as a driver of endothelial dysfunction in systemic sclerosis 104
Increased plasma levels of the VEGF165b splice variant are associated with the severity of nailfold capillary loss in systemic sclerosis 99
Progressive loss of lymphatic vessels in skin of patients with systemic sclerosis 98
Vascular biomarkers and correlation with peripheral vasculopathy in systemic sclerosis 97
Decreased circulating lymphatic endothelial progenitor cells in digital ulcer-complicated systemic sclerosis 97
Slit2/Robo4 axis may contribute to endothelial cell dysfunction and angiogenesis disturbance in systemic sclerosis 95
Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis 91
Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis 91
The contribution of mesenchymal transitions to the pathogenesis of systemic sclerosis 88
A candidate gene study reveals association between a variant of the SRp55 splicing factor gene and systemic sclerosis 86
STIMULATION OF SOLUBLE GUANYLATE CYCLASE (sGC) FOSTERS ANGIOGENESIS AND BLUNTS ENDOTHELIAL-TO-MESENCHYMAL TRANSITION (EndoMT) OF SYSTEMIC SCLEROSIS (SSc) DERMAL MICROVASCULAR ENDOTHELIAL CELLS 86
Systemic Sclerosis Serum Significantly Impairs the Multi-Step Lymphangiogenic Process: in Vitro Evidence 85
Stiff Skin Syndrome 83
Adipose-derived stem cells: Pathophysiologic implications vs therapeutic potential in systemic sclerosis 82
The Role of Pro-fibrotic Myofibroblasts in Systemic Sclerosis: From Origin to Therapeutic Targeting 78
The contribution of epigenetics to the pathogenesis and gender dimorphism of systemic sclerosis: a comprehensive overview 77
Evidence for caveolin-1 as a new susceptibility gene regulating tissue fibrosis in systemic sclerosis. 73
Increased circulating levels of interleukin 33 in systemic sclerosis correlate with early disease stage and microvascular involvement 73
Oral lactobacillus species in systemic sclerosis 71
Scleroderma-like Impairment in the Network of Telocytes/CD34+ Stromal Cells in the Experimental Mouse Model of Bleomycin-Induced Dermal Fibrosis 71
Decreased expression of the endothelial cell-derived factor EGFL7 contributes to impaired angiogenesis and vasculogenesis in systemic sclerosis 70
Extracellular lactic acidosis drives reprogramming of human subcutaneous adipocytes toward pathogenic myofibroblasts 69
The Soluble Guanylate Cyclase Stimulator BAY 41-2272 Attenuates Transforming Growth Factor β1-Induced Myofibroblast Differentiation of Human Corneal Keratocytes 69
FAS/FASL and TF/FVII Levels In Rheumatoid Arthritis Patients Treated With TNF Antagonists 69
Circulating Neurovascular Guidance Molecules and Their Relationship with Peripheral Microvascular Impairment in Systemic Sclerosis 68
Bosentan blocks the antiangiogenic effects of sera from systemic sclerosis patients: an in vitro study 68
A new avenue in the pathogenesis of systemic sclerosis: the molecular interface between the endothelial and the nervous systems 68
Decreased Serum Levels of SIRT1 and SIRT3 Correlate with Severity of Skin and Lung Fibrosis and Peripheral Microvasculopathy in Systemic Sclerosis 67
POS0613 THE ROLE OF MICROBIOTA IN DIFFERENT DISEASE STAGES OF SYSTEMIC SCLEROSIS: A POSSIBLE IMPACT IN GASTROINTESTINAL TRACT DISEASE ACTIVITY? 65
POS1593-HPR GASTROINTESTINAL INVOLVEMENT IS ALREADY REPORTED IN AN ITALIAN VEDOSS COHORT: RESULTS FROM A RHEUMATOLOGICAL NURSE ASSESSMENT 65
The contribution of endothelial cells to tissue fibrosis 63
Impairment in the telocyte/CD34+ stromal cell network in human rheumatoid arthritis synovium 62
Soluble guanylate cyclase stimulation fosters angiogenesis and blunts myofibroblast-like features of systemic sclerosis endothelial cells 60
Advances in Systemic Sclerosis: From Pathogenetic Pathways toward Novel Therapeutic Targets 60
Immunohistochemical and ultrastructural identification of telocytes in the lamina propria of human vaginal mucosa 58
Skin telocyte secretome as conditioned medium prevents profibrotic differentiation of skin fibroblasts into myofibroblasts 57
The authors' reply 57
Soluble guanylate cyclase stimulation fosters angiogenesis and blunts myofibroblast-like features of scleroderma endothelial cells 56
The differential crosstalk of the skin-gut microbiome axis as a new emerging actor in systemic sclerosis 55
ORAL MICROBIOME IN RHEUMATIC DISEASES.WHAT INVOLVEMENT? 54
New Insights into Profibrotic Myofibroblast Formation in Systemic Sclerosis: When the Vascular Wall Becomes the Enemy 53
Extracellular Lactic Acidosis of the Tumor Microenvironment Drives Adipocyte-to-Myofibroblast Transition Fueling the Generation of Cancer-Associated Fibroblasts 51
Increased Circulating Soluble Junctional Adhesion Molecules in Systemic Sclerosis: Association with Peripheral Microvascular Impairment 49
Current Trends in Vascular Biomarkers for Systemic Sclerosis: A Narrative Review 49
Blockade of Sialylation with Decrease in Polysialic Acid Levels Counteracts Transforming Growth Factor β1-Induced Skin Fibroblast-to-Myofibroblast Transition 48
Lymphatic Endothelial-to-Myofibroblast Transition: A Potential New Mechanism Underlying Skin Fibrosis in Systemic Sclerosis 47
Autoantibodies as putative biomarkers and triggers of cell dysfunctions in systemic sclerosis 47
Pharmacological Stimulation of Soluble Guanylate Cyclase Counteracts the Profibrotic Activation of Human Conjunctival Fibroblasts 45
The genetics of systemic sclerosis: an update. 42
Recent Insights into Cellular and Molecular Mechanisms of Defective Angiogenesis in Systemic Sclerosis 41
The differential crosstalk of the skin–gut microbiome axis as a new emerging actor in systemic sclerosis 35
Blockade of sialylation with decrease in polysialic acid levels counteracts transforming growth factor β1-induced skin fibroblast-to-myofibroblast transition 34
DECIPHERING THE GUT MICROBIOTA OF VERY EARLY SYSTEMIC SCLEROSIS (VEDOSS) PATIENTS: A TAXONOMIC AND FUNCTIONAL CHARACTERIZATION 31
Gut microbiota in very early systemic sclerosis: the first case-control taxonomic and functional characterisation highlighting an altered butyric acid profile 8
null 2
Totale 6.684
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.456
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.456
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020711 0 0 0 0 100 116 105 111 105 77 86 11
2020/2021749 47 61 35 111 30 58 63 50 83 125 39 47
2021/2022361 14 10 19 12 23 33 7 12 34 23 51 123
2022/20231.132 104 235 43 79 56 196 163 49 125 11 37 34
2023/2024594 14 60 85 31 46 81 36 112 10 33 41 45
2024/20252.318 120 393 272 583 950 0 0 0 0 0 0 0
Totale 6.684